Bath & Body WorksWBO:LBRA -4.01%62 Days Payable is 58.82 as of Apr. 2026, which is 66% above its 10-year median of 35.54. GuruFocus rates WBO:LBRA with a GF Score™ of 62/100 and a GF Value™ of €29.16 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,098 Retail - Cyclical companies, Bath & Body Works ranks worse than 51.37% on this metric.
The historical rank and industry rank for Bath & Body Works's Days Payable or its related term are showing as below:
WBO:LBRA'
s Days Payable Range Over the Past 10 Years
Min: 31.26 Med: 35.54 Max: 82.12
Current: 50.05
During the past 13 years, Bath & Body Works's highest Days Payable was 82.12. The lowest was 31.26. And the median was 35.54.
WBO:LBRA's Days Payable is ranked worse than 51.37% of 1098
companies
in the Retail - Cyclical industry
Industry Median: 51.755
vs WBO:LBRA: 50.05
Bath & Body Works's Days Payable
increased
from Apr. 2025 (48.02) to Apr. 2026 (58.82).
It may suggest that Bath & Body Worksdelayed paying its suppliers.
Bath & Body Works Days Payable Related Terms
Bath & Body Works Days Payable Historical Data
* Premium members only.
The historical data trend for Bath & Body Works's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:LBRA vs MNSO, RH, ASO: Days Payable Comparison
For the Specialty Retail subindustry, Bath & Body Works's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bath & Body Works Days Payable vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bath & Body Works's Days Payable distribution charts can be found below:
* The bar in red indicates where Bath & Body Works's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bath & Body Works's Days Payable for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bath & Body Works (WBO:LBRA) has a Days Payable of 58.82 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bath & Body Works and its competitors. This is 66% above median its historical median of 35.54. Over the past decade, Bath & Body Works' Days Payable has ranged from 31.26 to 82.12. According to the industry distribution chart, Bath & Body Works ranks #564 out of 1098 companies in the Retail - Cyclical industry, placing it in the top 51.4%.
Is Bath & Body Works' Days Payable too high?
Bath & Body Works' current Days Payable of 58.82 is 66% above median its 10-year median of 35.54. Over the past 10 years, this metric has ranged from a low of 31.26 to a high of 82.12. The Retail - Cyclical industry median Days Payable is 51.76. Bath & Body Works' value of 58.82 is 13.7% above this industry median. Based on the distribution chart, Bath & Body Works ranks #564 out of 1098 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Bath & Body Works has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bath & Body Works' Days Payable compare to MNSO and RH?
According to the Retail - Cyclical industry distribution chart, Bath & Body Works ranks #564 out of 1098 companies for Days Payable. This places Bath & Body Works in the lower half of its industry. The industry median Days Payable is 51.76. Bath & Body Works' value of 58.82 is 13.7% above this benchmark. Historically, Bath & Body Works' own Days Payable has ranged from 31.26 to 82.12 over the past decade. While the company's 10-year median is 35.54 vs. the industry median of 51.76, Bath & Body Works has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Retail - Cyclical company?
The median Days Payable among Retail - Cyclical companies is 51.76, based on 1,098 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bath & Body Works's current Days Payable of 58.82 is 13.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bath & Body Works and its competitors. For the Retail - Cyclical industry, the median Days Payable is 51.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bath & Body Works's current Days Payable is 58.82, which is 66% above median its own 10-year median of 35.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bath & Body Works stock overvalued right now?
Based on GuruFocus' analysis, Bath & Body Works (WBO:LBRA) is currently considered Significantly Undervalued. The stock's GF Value™ is €29.16, compared to a current price of €18.79 — trading 35.6% below its estimated fair value. The current Days Payable is 58.82, which is 66% above median its 10-year median of 35.54 and 13.7% above the Retail - Cyclical industry median of 51.76. Bath & Body Works' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bath & Body Works (WBO:LBRA), the current Days Payable is 58.82 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bath & Body Works (WBO:LBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Bath & Body Works stock appears to be undervalued.
The current stock price of €18.79 is trading 35.6% below its estimated GF Value™ of €29.16.
GuruFocus considers Bath & Body Works to be Significantly Undervalued.
Key valuation signals for WBO:LBRA:
Days Payable: 58.82 (66% above median its 10-year median of 35.54)
GF Value™: €29.16 vs. price of €18.79 (35.6% below fair value)
Industry Position: 13.7% above the Retail - Cyclical median (#564 of 1098)
No single metric tells the full story. See the WBO:LBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
62GF Score
Get the complete analysis for WBO:LBRA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:LBRA has been successfully added to your 
